AN2898

DB16039InvestigationalSmall molecule

AN2898 is under investigation in clinical trial NCT01301508 (Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-moderate Atopic Dermatitis).

Formula / weight: C₁₅H₉BN₂O₃ · 276.06 g/mol (avg)
Code names: AN-2898

Resolves to

Compound

UNII6O60L94RMBCAS906673-33-4

Structure

InChIKeyUBMGTTRDNUKZMT-UHFFFAOYSA-NSMILESOB1OCC2=C1C=CC(OC1=CC(C#N)=C(C=C1)C#N)=C2

Targets

P27815PDE4AQ07343PDE4BQ08499PDE4D

What you can answer from here — as of January 29, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with AN2898, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account